VHL and cancer: In clear cell renal cell carcinoma (ccRCC), but few other cancers, somatic loss-of-function mutations, chromosomal aberrations or promoter hypermethylation lead to decreased activity of von Hippel–Lindau tumour suppressor protein (pVHL).